Literature DB >> 21538686

A comprehensive review of reported heritable noggin-associated syndromes and proposed clinical utility of one broadly inclusive diagnostic term: NOG-related-symphalangism spectrum disorder (NOG-SSD).

Tommy A Potti1, Elizabeth M Petty, Marci M Lesperance.   

Abstract

The NOG gene encodes noggin, a secreted polypeptide that is important for regulating multiple signaling pathways during human development, particularly in cartilage and bone. The hallmark of NOG-related syndromes is proximal symphalangism, defined by abnormal fusion of the proximal interphalangeal joints of the hands and feet. Many additional features secondary to NOG mutations are commonly but inconsistently observed, including a characteristic facies with a hemicylindrical nose, congenital conductive hearing loss due to stapes fixation, and hyperopia. The variable clinical presentations led to the designation of five different autosomal dominant syndromes, all subsequently found to have resulted from NOG mutations. These include (1) proximal symphalangism; (2) multiple synostoses syndrome 1; (3) stapes ankylosis with broad thumbs and toes; (4) tarsal-carpal coalition syndrome; and (5) brachydactyly type B2. Herein, we review the phenotypic features associated with mutations in the NOG gene, demonstrating the overlapping characteristics of these syndromes. Due to the variable phenotypic spectrum within families and among families with the same mutation, we propose a unifying term, NOG-related symphalangism spectrum disorder (NOG-SSD), to aid in the clinical recognition and evaluation of all affected individuals with these phenotypes. These NOG gene variants are available in a new locus-specific database (https://NOG.lovd.nl).
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538686     DOI: 10.1002/humu.21515

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  24 in total

1.  Identification of two novel mutations in the NOG gene associated with congenital stapes ankylosis and symphalangism.

Authors:  Akira Ganaha; Tadashi Kaname; Yukinori Akazawa; Teruyuki Higa; Ayano Shinjou; Kenji Naritomi; Mikio Suzuki
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

Review 2.  The development of the mammalian outer and middle ear.

Authors:  Neal Anthwal; Hannah Thompson
Journal:  J Anat       Date:  2015-07-30       Impact factor: 2.610

3.  Temporal Bone Histopathology in NOG-Symphalangism Spectrum Disorder.

Authors:  Alicia M Quesnel; Joseph B Nadol; G Petur Nielsen; Hugh D Curtin; Marci M Lesperance
Journal:  Otol Neurotol       Date:  2015-12       Impact factor: 2.311

4.  A Novel GDF6 Mutation in a Family with Multiple Synostoses Syndrome without Hearing Loss.

Authors:  Ragnhild Drage Berentsen; Bjørn I Haukanes; Pétur B Júlíusson; Karen Rosendahl; Gunnar Houge
Journal:  Mol Syndromol       Date:  2018-08-15

Review 5.  Acro-osteolysis.

Authors:  Anna Botou; Athanasios Bangeas; Ioannis Alexiou; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2016-10-29       Impact factor: 2.980

6.  Molecular analysis of the Noggin (NOG) gene in holoprosencephaly patients.

Authors:  Kshitij Srivastava; Ping Hu; Benjamin D Solomon; Jeffrey E Ming; Erich Roessler; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-03-21       Impact factor: 4.797

Review 7.  TGFβ signalling in context.

Authors:  Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

8.  Mutational analysis of NOG in esophageal atresia and tracheoesophageal fistula patients.

Authors:  Andrew J Murphy; Yina Li; Joshua B Pietsch; Chin Chiang; Harold N Lovvorn
Journal:  Pediatr Surg Int       Date:  2011-11-15       Impact factor: 1.827

9.  Molecular and clinical delineation of the 17q22 microdeletion phenotype.

Authors:  Tobias Laurell; Johanna Lundin; Britt-Marie Anderlid; Jerome L Gorski; Giedre Grigelioniene; Samantha J L Knight; Ana C V Krepischi; Agneta Nordenskjöld; Susan M Price; Carla Rosenberg; Peter D Turnpenny; Angela M Vianna-Morgante; Ann Nordgren
Journal:  Eur J Hum Genet       Date:  2013-01-30       Impact factor: 4.246

10.  Multiple tissue-specific requirements for the BMP antagonist Noggin in development of the mammalian craniofacial skeleton.

Authors:  Maiko Matsui; John Klingensmith
Journal:  Dev Biol       Date:  2014-06-17       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.